Lander Foquet

Lander Foquet, PhD is a Principal Scientist at Addition Therapeutics, leading the in vivo team to find new gene therapy cures. Prior to this role, Lander worked as a Senior Researcher and In Vivo Infectious Disease Lead at The Janssen Pharmaceutical Companies of Johnson & Johnson and as an Associate Director, Scientific Applications at Yecuris Corporation. Lander also has experience as a Staff Scientist, Adjunct Professor, Study Director, Postdoctoral Fellow, PhD student, and Thesis student, where Lander developed various in vivo models and studied infectious diseases like malaria and HIV-1. Lander holds a Doctor of Medical Sciences degree in Biomedical Sciences from Ghent University.